# Intrathecal Amniotic Fluid Stem Cells for Progressive Multiple Sclerosis

> **NCT06841068** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Wake Forest University Health Sciences**

## Conditions studied

- Multiple Sclerosis, Progressive

## Interventions

- **BIOLOGICAL:** Amniotic fluid or placental CD117 stem cells

## Key facts

- **NCT ID:** NCT06841068
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2026-02
- **Primary completion:** 2026-08
- **Final completion:** 2026-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** lack of funding
- **Last updated:** 2026-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06841068

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06841068, "Intrathecal Amniotic Fluid Stem Cells for Progressive Multiple Sclerosis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06841068. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*